Hart, X. M.; Hiemke, C.; Clement, H. W. et al.
Therapeutic reference range for aripiprazole revised: A systematic review and combined analysisPHARMACOPSYCHIATRY. Bd. 55. H. 03. 2022 S. 166-166
Heinzelbecker, Julia; Schmidt, Stefanie; Lackner, Julia et al.
Therapy of clinical stage IIA and IIB seminoma: a systematic reviewWORLD JOURNAL OF UROLOGY. Bd. 40. H. 12. 2022 S. 2829-2841
Hartmann, Amely; Schmohl, Joerg; Cascant Ortolano, Lorena et al.
Therapy of Neurophysiological Changes after Oral and Maxillofacial Surgery-A Systematic ReviewAPPLIED SCIENCES-BASEL. Bd. 12. H. 3. 2022
Finke, Juergen; Schmoor, Claudia; Stelljes, Matthias et al.
Thiotepa-fludarabine-treosulfan conditioning for 2nd allogeneic HCT from an alternative unrelated donor for patients with AML: a prospective multicenter phase II trialBONE MARROW TRANSPLANTATION. Bd. 57. H. 11. 2022 S. 1664-1670
Karampinis, Ioannis; Al-Shammari, Abdullah; Hartley, Philip et al.
Thoracic surgery in patients on veno-venous extracorporeal membrane oxygenation for COVID-19 associated acute respiratory distress syndromePERFUSION-UK. 2022
Muenzel, Thomas; Gori, Tommaso
Those declared dead live longerCARDIOVASCULAR RESEARCH. 2022
Degirmenci, Yaman; Schepers, Markus; Steetskamp, Joscha et al.
Three-dimensional vs two-dimensional endoscopic approach in urogynecology: A retrospective cohort study of laparoscopic sacrocolpopexyJOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH. 2022
Voigtlaender, Minna; Edler, Carolin; Gerling, Moritz et al.
Thromboembolic events in deceased patients with proven SARS-CoV-2 infection: Frequency, characteristics and risk factorsTHROMBOSIS RESEARCH. Bd. 218. 2022 S. 171-176
Wenzel, Philip
Thromboinflammation in cardiovascular disease: lessons learned for the management of hypertension, heart failure, and aortic valve stenosisEUROPEAN HEART JOURNAL. Bd. 43. H. 44. 2022 S. 4611-4613
Zeuschner, Philip; Hoelters, Sebastian; Stoeckle, Michael et al.
Thrombospondin-2 and LDH: potential predictive biomarkers for the treatment of metastatic renal cell carcinoma with everolimus after one VEGF-targeted therapy (MARC-2 study)ONCOLOGY RESEARCH AND TREATMENT. Bd. 45. H. SUPPL 3. 2022 S. 99-99